/Companies

Telesis Bio

San Diego, US · Founded 2013 · Delaware corporation · 42 employees on LinkedIn · 2 known investors

Find your way into Telesis Bio

Sign up to see every warm intro you have to Telesis Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Telesis Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

Founders & leadership

Telesis Bio was founded in 2013 by Daniel G. Gibson and Todd R. Nelson.

DGDaniel G. Gibson
Daniel G. GibsonCo-founder · Chief Technology OfficerDaniel G. Gibson holds a Ph.D. from the University of Southern California and an undergraduate degree from SUNY Buffalo. He co-founded Telesis Bio in 2012 and serves as Chief Technology Officer, developing DNA synthesis technologies; earlier, he led synthetic biology research at the J. Craig Venter Institute and Synthetic Genomics, including work on synthetic genomes and cells.
TRTodd R. Nelson
Todd R. NelsonCo-founder
EEEric Esser
Eric EsserPresident and CEO at Telesis Bio
WF
William F. SniderNamed on SEC filing
ALAndrea L. Jackson
Andrea L. JacksonNamed on SEC filingPartner at Northpond Ventures
CA
Christine A. TsingosNamed on SEC filing
RH
Robert H. CutlerNamed on SEC filing
AV
Annette V. TumoloNamed on SEC filing
JN
Jami NachtsheimNamed on SEC filing

Board

PMPaul Meister
Paul MeisterBoard directorPartner at Novalis LifeSciences
FR
Franklin R. WitneyChair of the Board of Directors

Investors · 2

Funding

SEC filings, press & company announcements

$49M disclosed across 2 rounds · 2023–2025

▶$28MraisedJun 2023 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Franklin R. WitneyDirector
  • Eric EsserExecutive Officer
  • Paul MeisterDirector
  • William F. SniderDirector
  • Andrea L. JacksonDirector
  • Christine A. TsingosDirector
  • Robert H. CutlerExecutive Officer
  • Annette V. TumoloDirector
  • Jami NachtsheimDirector
  • Daniel G. GibsonExecutive Officer
  • Todd R. NelsonExecutive Officer, Director
Offering amount
$74.2M
Amount sold
$28M
Sales commissions
$850K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Telesis Bio.

In the news

Frequently asked questions

What does Telesis Bio do?
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.
Who founded Telesis Bio?
Telesis Bio was founded by Daniel G. Gibson, Todd R. Nelson in 2013.
Who are Telesis Bio's investors?
Telesis Bio's investors include Novalis LifeSciences, Northpond Ventures.
How much funding has Telesis Bio raised?
Telesis Bio has disclosed $49M raised across 2 rounds.
Where is Telesis Bio headquartered?
Telesis Bio is headquartered in San Diego, US.